Diabetes management platform Glooko racks up $16.5 mln Series B
Palo Alto, California-based diabetes management platform Glooko Inc has received $16.5 million in Series B funding. The investors included Canaan Partners, Medtronic, The Social + Capital Partnership and Samsung. In conjunction with the financing, Wende Hutton of Canaan Partners has been added to Glooko's board of directors.
17 March 2015•4 mins read
